Just as quickly, investors are losing their appetite for the trade. After a disappointing trial of a new Novo Nordisk drug ...
A report from The Lancet Diabetes & Endocrinology Commission has proposed new criteria for defining and diagnosing obesity, ...
Leading health experts challenge traditional BMI measurements and introduce a comprehensive new approach to diagnosing obesity, potentially affecting millions.
By Dr. Priyom Bose, Ph.D. Factors such as sex, type of insurance plan, and the use of common medications influenced whether ...
Obesity affects over 1 billion people globally, with 40 percent of U.S. adults classified as obese under the present ...
An international team of doctors proposed a new way to define obesity that's not based solely on BMI. Here's what they ...
Weight-loss medicines such as Ozempic might raise a person’s likelihood of developing conditions including arthritis.
Instead of using the controversial body mass index, or BMI, to assess weight, an international group of scientists proposes ...
An international commission made the case for focusing on body fat quantity and the illnesses people experience.
One of the world’s largest studies of Ozempic, Mounjaro and other blockbuster diabetes and obesity drugs highlighted their ...
In 2022, pharmaceutical giant Pfizer (NYSE: PFE) became the first healthcare company to generate $100 billion in annual sales ...